William K Lee1, Michael John S Milloy1,2, Ekaterina Nosova1, John Walsh3, Thomas Kerr1,2. 1. British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada. 2. Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. 3. Department of Education Psychology and Leadership Studies, University of Victoria, Victoria, British Columbia, Canada.
Abstract
BACKGROUND: Suboptimal adherence to antiretroviral therapy (ART) among people living with HIV/AIDS (PLWHA) who use illicit drugs remains an ongoing health concern. Although health outcomes associated with adherence self-efficacy have been well-documented, there is dearth research exploring the predictors of this construct. This study sought to identify possible determinants of adherence self-efficacy among a cohort of PLWHA who use illicit drugs. METHODS: From December 2004 to May 2014, we collected data from the AIDS Care Cohort to evaluate Exposure to Survival Services, a prospective cohort of adult PLWHA who use illicit drugs in Vancouver, Canada. We used multivariate generalized estimating equation analyses to identify longitudinal factors independently associated with higher adherence self-efficacy. RESULTS: Among 742 participants, 493 (66.4%) identified as male and 406 (54.7%) reported white ancestry. In multivariate generalized estimating equation analysis, older age at ART initiation (adjusted odds ratio [AOR] = 1.02, 95% confidence interval [CI]: 1.00 to 1.03) and recent year of baseline interview (AOR = 1.08, 95% CI: 1.05 to 1.11) were independently associated with higher adherence self-efficacy, whereas homelessness (AOR = 0.78, 95% CI: 0.65 to 0.94), ≥daily crack smoking (AOR = 0.81, 95% CI: 0.68 to 0.96), experienced violence (AOR = 0.82, 95% CI: 0.69 to 0.98), and childhood abuse (AOR = 0.75, 95% CI: 0.60 to 0.92) were negatively associated. CONCLUSIONS: These findings highlight the potential role that personal and contextual factors can play in predicting levels of ART adherence self-efficacy. Future research should seek to identify and validate strategies to optimize adherence self-efficacy.
BACKGROUND: Suboptimal adherence to antiretroviral therapy (ART) among people living with HIV/AIDS (PLWHA) who use illicit drugs remains an ongoing health concern. Although health outcomes associated with adherence self-efficacy have been well-documented, there is dearth research exploring the predictors of this construct. This study sought to identify possible determinants of adherence self-efficacy among a cohort of PLWHA who use illicit drugs. METHODS: From December 2004 to May 2014, we collected data from the AIDS Care Cohort to evaluate Exposure to Survival Services, a prospective cohort of adult PLWHA who use illicit drugs in Vancouver, Canada. We used multivariate generalized estimating equation analyses to identify longitudinal factors independently associated with higher adherence self-efficacy. RESULTS: Among 742 participants, 493 (66.4%) identified as male and 406 (54.7%) reported white ancestry. In multivariate generalized estimating equation analysis, older age at ART initiation (adjusted odds ratio [AOR] = 1.02, 95% confidence interval [CI]: 1.00 to 1.03) and recent year of baseline interview (AOR = 1.08, 95% CI: 1.05 to 1.11) were independently associated with higher adherence self-efficacy, whereas homelessness (AOR = 0.78, 95% CI: 0.65 to 0.94), ≥daily crack smoking (AOR = 0.81, 95% CI: 0.68 to 0.96), experienced violence (AOR = 0.82, 95% CI: 0.69 to 0.98), and childhood abuse (AOR = 0.75, 95% CI: 0.60 to 0.92) were negatively associated. CONCLUSIONS: These findings highlight the potential role that personal and contextual factors can play in predicting levels of ART adherence self-efficacy. Future research should seek to identify and validate strategies to optimize adherence self-efficacy.
Authors: Mallory O Johnson; Margaret A Chesney; Rise B Goldstein; Robert H Remien; Sheryl Catz; Cheryl Gore-Felton; Edwin Charlebois; Stephen F Morin Journal: AIDS Patient Care STDS Date: 2006-04 Impact factor: 5.078
Authors: Jane Loh; Mary Clare Kennedy; Evan Wood; Thomas Kerr; Brandon Marshall; Surita Parashar; Julio Montaner; M-J Milloy Journal: AIDS Care Date: 2016-06-01
Authors: Cathy M Puskas; Angela Kaida; Cari L Miller; Wendy Zhang; Benita Yip; Neora Pick; Julio S G Montaner; Robert S Hogg Journal: AIDS Date: 2017-03-27 Impact factor: 4.177
Authors: Matthias Egger; Margaret May; Geneviève Chêne; Andrew N Phillips; Bruno Ledergerber; François Dabis; Dominique Costagliola; Antonella D'Arminio Monforte; Frank de Wolf; Peter Reiss; Jens D Lundgren; Amy C Justice; Schlomo Staszewski; Catherine Leport; Robert S Hogg; Caroline A Sabin; M John Gill; Bernd Salzberger; Jonathan A C Sterne Journal: Lancet Date: 2002-07-13 Impact factor: 79.321
Authors: Thibaut Davy-Mendez; Eric Vittinghoff; Samantha E Dilworth; Leslie W Suen; Carl Braun; Phillip O Coffin; Derek D Satre; Elise D Riley Journal: Drug Alcohol Depend Date: 2021-09-22 Impact factor: 4.492
Authors: Duncan Short; Xueqi Wang; Shivali Suri; Thomas K Hsu; Bryn Jones; Rob J Fredericksen; Heidi M Crane; Alexandra Musten; Jean Bacon; Yongwei Wang; Kevin A Gough; Moti Ramgopal; Jeff Berry; William B Lober Journal: Patient Prefer Adherence Date: 2022-09-05 Impact factor: 2.314